CVS Health Corporation revised earnings guidance for the full year 2024. For the year, the company expects GAAP diluted EPS guidance to at least $5.64 from at least $7.06.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.32 USD | -0.14% | +2.36% | -27.41% |
05-21 | News Highlights : Top Company News of the Day - Tuesday at 1 PM ET | DJ |
05-21 | News Highlights : Top Company News of the Day - Tuesday at 11 AM ET | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.41% | 71.96B | |
+18.63% | 84.11B | |
+2.04% | 27.25B | |
-9.66% | 17.31B | |
-2.14% | 16.83B | |
+3.96% | 15.92B | |
+7.75% | 13.68B | |
+72.83% | 13.29B | |
+72.50% | 12.73B | |
+2.69% | 12.62B |
- Stock Market
- Equities
- CVS Stock
- News CVS Health Corporation
- CVS Health Corporation Revises Earnings Guidance for the Full Year 2024